Insmed (INSM) Receivables - Net (2018 - 2026)
Insmed's Receivables - Net history spans 11 years, with the latest figure at $178.6 million for Q1 2026.
- Quarterly Receivables - Net rose 273.97% to $178.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $178.6 million through Mar 2026, up 273.97% year-over-year, with the annual reading at $140.9 million for FY2025, 170.82% up from the prior year.
- Receivables - Net came in at $178.6 million for Q1 2026, up from $140.9 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $178.6 million in Q1 2026 to a low of $25.7 million in Q1 2022.
- The 5-year median for Receivables - Net is $40.3 million (2024), against an average of $53.5 million.
- Year-over-year, Receivables - Net grew 4.97% in 2023 and then soared 273.97% in 2026.
- Insmed's Receivables - Net stood at $29.7 million in 2022, then surged by 38.62% to $41.2 million in 2023, then increased by 26.28% to $52.0 million in 2024, then surged by 170.82% to $140.9 million in 2025, then increased by 26.76% to $178.6 million in 2026.
- Per Business Quant, the three most recent readings for INSM's Receivables - Net are $178.6 million (Q1 2026), $140.9 million (Q4 2025), and $65.3 million (Q3 2025).